Grifols S.A. (GRFS) |
|
18.97 0.02 (0.11%)
|
04-25 15:51 |
|
Open: |
18.99 |
Pre. Close: |
18.95 |
|
High:
|
19.0664 |
Low:
|
18.89 |
|
Volume:
|
903,585 |
Market Cap:
|
16676M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
19.052 - 19.143 |
19.143 - 19.226 |
|
Low:
|
18.561 - 18.669 |
18.669 - 18.767 |
|
Close:
|
18.774 - 18.95 |
18.95 - 19.109 |
|
|
|
Technical analysis |
as of: 2019-04-25 3:30:29 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 22.90 One year: 23.84 |
| Support: |
Support1: 18.30 Support2: 15.23 |
| Resistance: |
Resistance1: 19.60 Resistance2: 20.41 |
| Pivot: |
19.34  |
| Moving Average: |
MA(5): 18.80  MA(20): 19.49
MA(100): 19.12 MA(250): 20.41 |
| MACD: |
MACD(12,26): -0.15 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 33.69 %D(3): 23.73 |
| RSI: |
RSI(14): 44.72 |
| 52-week: |
High: 24.97 Low: 17.42 Change(%): -6.1 |
| Average Vol(K): |
3-Month: 87764 10-Days: 145523 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.GRFS has closed above bottom band by 32.2%. Bollinger Bands are 13.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 23 Apr 2019 15:10:01 Z
European ADRs Move Lower in Tuesday Trading
Mon, 22 Apr 2019 20:29:19 Z
Health Care Sector Update for 04/22/2019: ENZ,HOLX,GRFS,TNXP,MBRX,ISRG
Wed, 17 Apr 2019 20:57:00 Z
After Hours Most Active for Apr 17, 2019 : VEON, XOG, VNET, GRFS, QCOM, INTC
Wed, 10 Apr 2019 15:24:20 Z
European ADRs Move Lower in Wednesday Trading
Wed, 10 Apr 2019 02:05:48 Z
Here's Why Rigel Pharmaceuticals Gained 17.3% in March
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
683.74 |
| Shares Float (M) |
683.74 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
32.50 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est. Current Year
|
1.210 |
|
EPS Est. Next Year
|
1.340 |
|
EPS Est. Next Quarter
|
0.310 |
|
Forward EPS
|
1.550 |
|
Book Value (p.s.)
|
2.890 |
|
PEG Ratio
|
1.41 |
|
Profit Margin
|
13.02 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
5.0 |
|
Return on Equity (ttm)
|
14.9 |
|
Qtrly Rev. Growth
|
14.5 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
-44.40 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
|
|
P/BV
|
6.57 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
1.802 |
|
Dividend Yield
|
0.09 |
|
Dividend Pay Date
|
2018-12-11 |
|
Ex-Dividend Date
|
2018-11-30 |
|
Forward Dividend
|
0.460 |
|
Last Split Date
|
2016-01-04 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
